Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function - PubMed (original) (raw)

Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function

Ye Zheng et al. J Exp Med. 2003.

Abstract

Signaling pathways involved in regulating T cell proliferation and survival are not well understood. Here we have investigated a possible role of the nuclear factor (NF)-kappaB pathway in regulating mature T cell function by using CD4+ T cells from p50-/- cRel-/- mice, which exhibit virtually no inducible kappaB site binding activity. Studies with these mice indicate an essential role of T cell receptor (TCR)-induced NF-kappaB in regulating interleukin (IL)-2 expression, cell cycle entry, and survival of T cells. Our results further indicate that NF-kappaB regulates TCR-induced expression of antiapoptotic Bcl-2 family members. Strikingly, retroviral transduction of CD4+ T cells with the NF-kappaB-inducing IkappaB kinase beta showed that NF-kappaB activation is not only necessary but also sufficient for T cell survival. In contrast, our results indicate a lack of involvement of NF-kappaB in both IL-2 and Akt-induced survival pathways. In vivo, p50-/- cRel-/- mice showed impaired superantigen-induced T cell responses as well as decreased numbers of effector/memory and regulatory CD4+ T cells. These findings provide the first demonstration of a role for NF-kappaB proteins in regulating T cell function in vivo and establish a critically important function of NF-kappaB in TCR-induced regulation of survival.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Combined absence of p50 and cRel NF-κB subunits does not affect T cell development. (A) FACS® analysis of CD4 and CD8 expression in WT and p50−/− cRel−/− thymocytes. (B) FACS® analysis of B220, CD3, CD4, and CD8 expression in WT and p50−/− cRel−/− splenocytes. (C) CD3 expression level in WT and p50−/− cRel−/− CD4+ T cells. FACS® was performed by gating on CD4+ cells. (D) EMSAs were performed with nuclear extracts from naive CD4+ T cells either untreated or activated with 1 μg/ml plate-bound αCD3 or 1 μg/ml plate-bound αCD3 plus 1 μg/ml αCD28 for 6 h. NF-κB binding sites used were from H-2K_b_and IL-Rα (CD25). Complexes 1 and 2 are described in the text. (E) EMSAs were performed with nuclear extracts from naive CD4+ T cells activated with 1 μg/ml plate-bound αCD3 plus 1 μg/ml αCD28 for 6 h. NF-κB binding site was from H-2K_b_. The addition of antibodies to RelA and p100/p52 is indicated.

Figure 2.

Figure 2.

Impaired cell cycle entry and survival after TCR stimulation of p50−/− cRel−/− T cells. (A) WT and p50−/− cRel−/− CD4+ T cells were activated with plate-bound αCD3, αCD3+IL-2, αCD3+αCD28, or αCD3+ αCD28+IL-2 for 2 d before DNA content staining and FACS® were performed. The percentages show the sub-G0 population, which represents apoptotic cells and cells in different phases of the cell cycle. Typical results of several independent experiments are shown. (B) RT-PCR was performed to determine expression of IL-2, c-Myc, Bcl2, and Bcl-XL in WT and p50−/− cRel−/− CD4+ T cells after 6 h of activation.

Figure 3.

Figure 3.

Impaired cell division of p50−/− cRel−/− CD4+ T cells after activation. (A and B) WT and p50−/− cRel−/− CD4+ T cells were CFSE labeled and activated under different conditions as shown for 1–3 d. FACS® was performed on viable cells by gating on the forward and side scatter characteristics. As shown in the bottom right of B, peaks/shoulders represent the number of times cells underwent division. The percentage indicates cell population that has divided at least once. (C) FACS® analysis of CD25 (IL-2Rα) expression on WT and p50−/− cRel−/− CD4+ T cells after 3 d of activation by plate-bound αCD3+αCD28 and IL-2.

Figure 4.

Figure 4.

High susceptibility of activated p50−/− cRel−/− T cells to cell death can be rescued by Bcl-2. (A) WT and p50−/− cRel−/− CD4+ T cells were activated by plate-coated αCD3+αCD28 for 3 d after which dead cells were removed on a Ficoll gradient. These cells were either stained with PE-αCD25 and SYTOX immediately (day 0) or cultured in T cell medium without αCD3 or IL-2 for 24 h before PE-αCD25 and SYTOX staining (day 1). Apoptosis rate represent the percentage of CD25+ SYTOX+ cells (apoptotic) in the total CD25+ population. (B) p50−/− cRel−/− CD4+ T cells were infected with MIG retrovirus during a 4-d stimulation in the presence of αCD3+ αCD28. On day 4, viable cells were stained by αCD25 before FACS® analysis. (C) MIG and Bcl2 retroviral-infected WT and p50−/− cRel−/− CD4+ T cells were obtained as described in B, and either stained with PI and analyzed by FACS® immediately (day 0) or cultured in T cell medium without αCD3 or IL-2 for 2 d before PI staining and FACS® (day 2). The viable infected cells were GFP+ PI−. The percentage was calculated based on the percentage of GFP+ PI− cells in the total cell population. The increase in the percentage of Bcl-2–infected cells after 2 d in this experiment is likely due to the decrease in the number of uninfected cells because of cell death, rather than an increase in the absolute number of Bcl-2–infected cells.

Figure 5.

Figure 5.

IL-2–induced survival pathway does not require p50+cRel. αCD3+αCD28–activated WT and p50−/− cRel−/− CD4+ T cells were cultured in T cell medium alone or in the presence of 20 ng/ml IL-2 for 1 or 2 d. Cell death was determined by DNA content staining and sub-G0 quantification.

Figure 6.

Figure 6.

NF-κB activation is sufficient to promote T cell survival. (A) αCD3+αCD28+IL-2–activated WT CD4+ T cells were either used to make nuclear extract immediately or cultured in T cell medium without stimulation for 12 h before nuclear extract was made. EMSA was performed with an H2 site probe. The two complexes are described in the text. (B) MIG and CA-IKKβ retrovirus-infected WT CD4+ T cells were used immediately (0 h) or cultured in T cell medium without stimulation for 12 h. Nuclear extracts were made and EMSA was performed with the H2 site probe. (C and D) MIG, CA-IKKβ, and Bcl2 retrovirus-infected WT T cells were cultured in T cell medium without stimulation for 0, 1, 2, or 3 d, after which cells were stained with PI and analyzed by FACS®. FACS® data on days 0 and 3 are shown in C. The percentage indicates the proportion of GFP+ PI− cells in total cell population. The percentage survival of infected T cells from days 0 to 3 are shown in D. (E) MIG, CA-IKKβ, and Bcl2 retroviral-infected WT T cells were cultured in T cell medium without αCD3 or IL-2 for 12 h. RNA was extracted before and after culturing. Bcl2, Bcl-XL, and β actin expression was examined by Northern blotting. 1, endogenously expressed Bcl2; 2, ectopically expressed Bcl2. (F) MIG, CA-IKKβ retrovirus-infected OT-II×IL-2+/+ and OT-II×IL-2−/− T cells were cultured in T cell medium without stimulation for 0–3 d. Survival rate of the infected cells was determined by PI staining and FACS® analysis as in C and D.

Figure 7.

Figure 7.

Lack of involvement of p50+cRel in Akt-induced T cell survival. MIG, myr-AKT, and CA-IKKβ retrovirus-infected WT and p50−/− cRel−/− CD4+ T cells were cultured in T cell medium without αCD3 or IL-2 for 1 or 2 d. Survival rate of the infected cells was determined by PI staining and FACS® analysis as in Fig. 6, C and D.

Figure 8.

Figure 8.

Impaired antigen-induced responses and effector/memory and regulatory T cell generation in WT and p50−/− cRel−/− mice. (A) WT and p50−/− cRel−/− mice were either uninjected (day 0) or injected with SEB. Vβ8+ and Vβ6+ T cell populations were determined 3 and 6 d after injection. Two mice of each genotype were used per condition. (B) Naive and memory T cell populations were determined using 3- and 8-wk-old WT and p50−/− cRel−/− mice. Splenocytes from these mice were stained with CD4, CD44, and CD62L antibodies. FACS® analysis was performed on gated CD4+ T cells. Naive T cells were CD44low CD62L+ and memory T cells were CD44high CD62L−. (C) Splenocytes from 2-mo-old WT and p50−/− cRel−/− mice were stained with CD4 and CD25. FACS® analysis was performed on gated CD4+ T cells.

Similar articles

Cited by

References

    1. Kane, L.P., J. Lin, and A. Weiss. 2000. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12:242–249. - PubMed
    1. Frauwirth, K.A., and C.B. Thompson. 2002. Activation and inhibition of lymphocytes by costimulation. J. Clin. Invest. 109:295–299. - PMC - PubMed
    1. Jenkins, M.K., A. Khoruts, E. Ingulli, D.L. Mueller, S.J. McSorley, R.L. Reinhardt, A. Itano, and K.A. Pape. 2001. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19:23–45. - PubMed
    1. Van Parijs, L., and A.K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 280:243–248. - PubMed
    1. Lenardo, M., K.M. Chan, F. Hornung, H. McFarland, R. Siegel, J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:221–253. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources